Masterclass: DTx Reimbursement in the US: PBMs as Coverage Scale Catalysts

 Even though demonstrating evidence, building stakeholder advocacy and achieving desired regulatory status are important steps in the DTx commercialization journey, enabling reimbursement pathways at scale is a key adoption condition needed for higher DTx revenue potential. However, most DTx companies struggle to get their products reimbursed. In this masterclass led by Mike Pace we will focus on Pharmacy Benefit Managers (PBMs) as an entry point to DTx reimbursement in the US. Mike will walk us through: